The agreement provides Intermedica with the rights to sell in Russia, Belarussia, Kazakstan and the Ukraine, and includes minimum purchase requirements.
The Sonablate SB500, a high intensity focused ultrasound-based, image-guided, acoustic ablation system is developed by Focus Surgery.
Michael McManus, Jr, president and CEO of Misonix, said: “By building relationships with highly regarded clinical opinion leaders, who function as reference sites, Intermedica has demonstrated their ability to effectively educate their markets to the benefits of new and exciting technologies.”